-
1دورية أكاديمية
المؤلفون: Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M
المصدر: Biologics: Targets & Therapy, Vol Volume 13, Pp 13-21 (2019)
مصطلحات موضوعية: Pediatric Crohn disease, Infliximab failure, Adalimumab efficacy, Adalimumab safety, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://www.dovepress.comTest/efficacy-of-adalimumab-as-second-line-therapy-in-a-pediatric-cohort-of-peer-reviewed-article-BTT; https://doaj.org/toc/1177-5491Test
-
2دورية أكاديمية
المؤلفون: Alvisi P., Arrigo S., Cucchiara S., Lionetti P., Miele E., Romano C., Ravelli A., Knafelz D., Martelossi S., Guariso G., Accomando S., ZUIN, GIANNI, DE GIACOMO, Carlo, Balzani L., GENNARI, MARA MADDALENA, Aloi M.
المساهمون: Alvisi, P., Arrigo, S., Cucchiara, S., Lionetti, P., Miele, E., Romano, C., Ravelli, A., Knafelz, D., Martelossi, S., Guariso, G., Accomando, S., Zuin, Gianni, DE GIACOMO, Carlo, Balzani, L., Gennari, MARA MADDALENA, Aloi, M.
مصطلحات موضوعية: adalimumab efficacy, adalimumab safety, infliximab failure, pediatric crohn’s disease
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30655661; info:eu-repo/semantics/altIdentifier/wos/WOS:000457552200001; volume:13; firstpage:13; lastpage:21; numberofpages:9; journal:BIOLOGICS; http://hdl.handle.net/11573/1282068Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85060618108
-
3
المؤلفون: Giovanna Zuin, Erasmo Miele, Marina Aloi, Paolo Lionetti, Claudio Romano, Monia Gennari, Salvatore Accomando, Alberto Ravelli, Stefano Martelossi, Patrizia Alvisi, Costantino De Giacomo, Lucio Balzani, Graziella Guariso, Serena Arrigo, Salvatore Cucchiara, Daniela Knafelz
المساهمون: Alvisi, Patrizia, Arrigo, Serena, Cucchiara, Salvatore, Lionetti, Paolo, Miele, Erasmo, Romano, Claudio, Ravelli, Alberto, Knafelz, Daniela, Martelossi, Stefano, Guariso, Graziella, Accomando, Salvatore, Zuin, Giovanna, De Giacomo, Costantino, Balzani, Lucio, Gennari, Monia, Aloi, Marina, Alvisi P., Arrigo S., Cucchiara S., Lionetti P., Miele E., Romano C., Ravelli A., Knafelz D., Martelossi S., Guariso G., Accomando S., Zuin G., De Giacomo C., Balzani L., Gennari M., Aloi M.
المصدر: Biologics : Targets & Therapy
مصطلحات موضوعية: medicine.medical_specialty, Population, adalimumab efficacy, 03 medical and health sciences, 0302 clinical medicine, adalimumab safety, infliximab failure, pediatric crohn’s disease, Rheumatology, Internal medicine, medicine, Adalimumab, Immunology and Allergy, Targets and Therapy [Biologics], Pharmacology (medical), Adverse effect, education, Pediatric gastroenterology, Original Research, Crohn's disease, education.field_of_study, business.industry, Adalimumab efficacy, Adalimumab safety, Infliximab failure, Pediatric Crohn’s disease, Oncology, Gastroenterology, Hepatology, medicine.disease, Infliximab, 030220 oncology & carcinogenesis, Cohort, pediatric Crohn’s disease, 030211 gastroenterology & hepatology, business, medicine.drug
وصف الملف: text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3e036c24e71f4ebeae9b5a49196447Test
http://europepmc.org/articles/PMC6322517Test -
4دورية أكاديمية
المؤلفون: Coombs, J.H., Bloom, B.J., Breedveld, F.C., Fletcher, M.P., Gruben, D., Kremer, J.M., Burgos-Vargas, R., Wilkinson, B., Zerbini, C.A.F., Zwillich, S.H.
المصدر: Annals of the Rheumatic Diseases
مصطلحات موضوعية: quality-of-life combination therapy monoclonal-antibody reported outcomes methotrexate etanercept adalimumab efficacy safety
العلاقة: lumc-id: 5605810; https://hdl.handle.net/1887/111426Test
-
5
المؤلفون: Codullo, V., Iannone, F., Sinigaglia, L., Ennio Giulio Favalli, Sarzi-Puttini, P., Atzeni, F., Ferraccioli, G., Gremese, E., Carletto, A., Giollo, A., Govoni, M., Bergossi, F., Galeazzi, M., Cantarini, L., Salaffi, F., Di Carlo, M., Bazzani, C., Pellerito, R., Sebastiani, M., Ramonda, R., Lapadula, G., Caporali, R.
المصدر: Publons
Scopus-Elsevier
Web of Scienceمصطلحات موضوعية: rheumatoid arthritis, Adult, Male, efficacy, Severity of Illness Index, Arthritis, Rheumatoid, Economica, Adalimumab, Adrenal Cortex Hormones, Aged, Antirheumatic Agents, Drug Therapy, Combination, Female, Humans, Italy, Methotrexate, Middle Aged, Remission Induction, Treatment Failure, Registries, Drug Therapy, Rheumatoid, adalimumab, rheumatoid arthritis, Arthritis, anti-TNF, rheumatoid arthritis, adalimumab, efficacy, anti-TNF, Combination
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::928f4060436d5feb97f9f958c63f074dTest
https://publons.com/publon/9945029Test/